Series A financings start to slow

Fewer biotechs raised series A rounds in the first four months of 2023 than in the same period in the previous four years

May 17, 2023 10:07 PM UTC

The effects of the biotech bear market may finally be trickling down to early-stage venture.

Despite the down market persisting for all of 2022, biotech series A financings remained strong during the year, both in terms of total dollars raised and the percentage of the industry’s venture rounds that were series A versus later rounds...